Search | IOVS | ARVO Journals

Showing 1 – 20 of 107

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Comparing the efficacy of bevacizumab to ranibizumab in patients with diabetic macular edema: the BRDME study

Maartje J.C. Vader; Ann-Sofie M.E. Schauwvlieghe; Frank D Verbraak; Greetje Dijkman; Johanna M.M. Hooymans; Leonie I. Los; Aeilko H. Zwinderman; Tunde Peto; Carel B. Hoyng; Redmer van Leeuwen; Johannes R. Vingerling; Annette C. Moll; Janneke J.C. van Lith-Verhoeven; Marcel G.W. Dijkgraaf; Reinier O. Schlingemann

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3648. doi:

ARVO Annual Meeting Abstract July 2019

Prevalence and severity of macular holes in an ageing population from Northern Ireland

catherine Jamison; Nicola B Quinn; Usha Chakravarthy; Tunde Peto; Frank Kee; Ian Young; Bernadette McGuinness; Ruth Hogg

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3951. doi:

ARVO Annual Meeting Abstract July 2019

Prevalence of pathologies of the vitreo-macular interface – results from the Gutenberg Health Study

Alexander Karl-Georg Schuster; Anne K Kluck; Christina A Korb; Bernhard Stoffelns; Stefan Nickels; Andreas Schulz; Thomas Münzel; Philipp S. Wild; Manfred Beutel; Irene Schmidtmann; Karl J Lackner; Tunde Peto; Norbert Pfeiffer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3954. doi:

ARVO Annual Meeting Abstract July 2019

Comparison of Colour Fundus Photography and Ultra-wide field retinal imaging in the detection of choroidal naevi in an ageing population

Nicola B Quinn; Sophia Rachael Halliday; DAVID WRIGHT; Usha Chakravarthy; Tunde Peto; Frank Kee; Ian Young; Bernadette McGuinness; Ruth Hogg

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3955. doi:

ARVO Annual Meeting Abstract July 2019

Retinal morphology and risk factors for the development of macular atrophy during extended follow up in the IVAN trial

Usha Chakravarthy; Tunde Peto; Rebecca Evans; Simon P Harding; Barney Reeves

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4223. doi:

ARVO Annual Meeting Abstract July 2019

Clinical characteristics of diabetes and diabetic retinopathy in an ageing population - NICOLA study

Sophia Rachael Halliday; Nicola B Quinn; Ruth Hogg; Usha Chakravarthy; Tunde Peto; Frank Kee; Ian Young; Bernadette McGuinness; Sharon Cruise; DAVID WRIGHT

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1079. doi:

ARVO Annual Meeting Abstract July 2019

Do Quantitative Retinal Vascular Parameters Depend on Angle of Gaze in Patients with Diabetic Macular Edema?

Katrine Hartmund Frederiksen; Tunde Peto; Jakob Grauslund; Soeren Leer Blindbaek

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1583. doi:

ARVO Annual Meeting Abstract July 2019

Ultrawide-field retinal imaging markers for atypical and typical Alzheimer's disease

Imre Lengyel; Lajos Csincsik; Nicola Quinn; Tom MacGillivray; Timothy Shakespeare; Sebastian Crutch; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2198. doi:

ARVO Annual Meeting Abstract July 2019

Aflibercept and navigated versus conventional laser in diabetic macular edema: a 12-month prospective, randomized clinical trial.

Søren Leer Blindbæk; Tunde Peto; Jakob Grauslund

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2627. doi:

ARVO Annual Meeting Abstract July 2019

Optical coherence tomography angiography changes before and after panretinal photocoagulation in patients with treatment-naïve proliferative diabetic retinopathy

Anna Stage Vergmann; Tien Y Wong; Ryo Kawasaki; Tunde Peto; Jakob Grauslund

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3010. doi:

ARVO Annual Meeting Abstract July 2019

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Ferenc B Sallo; Vincent Rocco; Irene Leung; Adam M Dubis; Ute EK Wolf-Schnurrbusch; Catherine A Egan; Tunde Peto; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5049. doi:

ARVO Annual Meeting Abstract July 2019

Retinal vascular geometry measures as prognostic markers for successful panretinal photocoagulation in patients with proliferative diabetic retinopathy

Thomas Lee Torp; Ryo Kawasaki; Tien Y Wong; Tunde Peto; Jakob Grauslund

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5341. doi:

ARVO Annual Meeting Abstract July 2019

Prevalence of Age-related macular degeneration using multi-modal retinal imaging in a population based aging cohort: the NICOLA Study

Ruth Esther Hogg; Nicola B Quinn; Tunde Peto; DAVID WRIGHT; Bernadette McGuinness; Ian Young; Frank Kee; Usha Chakravarthy

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):63. doi:

ARVO Annual Meeting Abstract July 2019

Fequency of intra- and extralesional macular atrophy in the IVAN Follow-up trial

Tunde Peto; Rebecca Evans; Barney Reeves; Usha Chakravarthy

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):84. doi:

ARVO Annual Meeting Abstract July 2019

Is Poor Compliance with Diabetic Eye Screening in Young Adults an Indicator of Poor Diabetes Control?

Laura Nicole Cushley; Aaron Bell; Giuliana Silvestri; Una Graham; David McCance; Nicola Quinn; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1081. doi:

ARVO Annual Meeting Abstract July 2019

A New Classification for Macular Telangiectasia type 2 based on multi-modal imaging

Emily Y Chew; Tunde Peto; Traci E Clemons; Daniel Pauleikhoff; Ferenc B Sallo; Tjebo Heeren; Catherine A Egan; Peter Charbel Issa; Konstatinos Balaskas; Alan C Bird

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1335. doi:

ARVO Annual Meeting Abstract July 2019

Treatment response based on topography of retinal neovascularization in proliferative diabetic retinopathy

Sandra Halim; Amy A Kirkwood; Tunde Peto; Usha Chakravarthy; Jayashree Ramu; Philip G Hykin; Sobha Sivaprasad

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6555. doi:

Retina May 2019

Topical Treatment With Brimonidine and Somatostatin Causes Retinal Vascular Dilation in Patients With Early Diabetic Retinopathy From the EUROCONDOR

PDF

Jakob Grauslund; Ulrik Frydkjaer-Olsen; Tunde Peto; Jimena Fernández-Carneado; Berta Ponsati; Cristina Hernández; José Cunha-Vaz; Rafael Simó; for the EUROCONDOR
TAGS: diabetes mellitus, diabetes mellitus, type 2, diabetic retinopathy, dilatation, pathologic, somatostatin, brimonidine, retinal vascular caliber
Invest. Ophthalmol. Vis. Sci.. 2019; 60(6):2257-2262. doi: 10.1167/iovs.18-26487

ARVO Annual Meeting Abstract July 2018

Diabetes mellitus in MacTel Can Diabetes Mellitus be a negative prognosticator in MacTel?

Daniela Florea; Tatiana Mansour; Traci Clemons; Konstantinos Balaskas; Catherine Egan; Tunde Peto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1034. doi:

ARVO Annual Meeting Abstract July 2018

Ocular manifestation of Posterior Cortical Atrophy

Lajos Csincsik; Timothy Shakespeare; Sebastian Crutch; Tunde Peto; Imre Lengyel

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1130. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Comparing the efficacy of bevacizumab to ranibizumab in patients with diabetic macular edema: the BRDME study

Prevalence and severity of macular holes in an ageing population from Northern Ireland

Prevalence of pathologies of the vitreo-macular interface – results from the Gutenberg Health Study

Comparison of Colour Fundus Photography and Ultra-wide field retinal imaging in the detection of choroidal naevi in an ageing population

Retinal morphology and risk factors for the development of macular atrophy during extended follow up in the IVAN trial

Clinical characteristics of diabetes and diabetic retinopathy in an ageing population - NICOLA study

Do Quantitative Retinal Vascular Parameters Depend on Angle of Gaze in Patients with Diabetic Macular Edema?

Ultrawide-field retinal imaging markers for atypical and typical Alzheimer's disease

Aflibercept and navigated versus conventional laser in diabetic macular edema: a 12-month prospective, randomized clinical trial.

Optical coherence tomography angiography changes before and after panretinal photocoagulation in patients with treatment-naïve proliferative diabetic retinopathy

Blue-light reflectance imaging in macular telangiectasia type 2 (MacTel) using two different SLO systems.

Retinal vascular geometry measures as prognostic markers for successful panretinal photocoagulation in patients with proliferative diabetic retinopathy

Prevalence of Age-related macular degeneration using multi-modal retinal imaging in a population based aging cohort: the NICOLA Study

Fequency of intra- and extralesional macular atrophy in the IVAN Follow-up trial

Is Poor Compliance with Diabetic Eye Screening in Young Adults an Indicator of Poor Diabetes Control?

A New Classification for Macular Telangiectasia type 2 based on multi-modal imaging

Treatment response based on topography of retinal neovascularization in proliferative diabetic retinopathy

Topical Treatment With Brimonidine and Somatostatin Causes Retinal Vascular Dilation in Patients With Early Diabetic Retinopathy From the EUROCONDOR

Diabetes mellitus in MacTel Can Diabetes Mellitus be a negative prognosticator in MacTel?

Ocular manifestation of Posterior Cortical Atrophy

To View More...

You must be signed into an individual account to use this feature.